Archive for February, 2012

Can Waste Gasification Quell A Future Energy Crisis?

This is a guest post from the BiotechBlog Intern,  Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin City University. Do you have a response to Fintan’s post? Respond in the comments section below. One of the most overlooked but consistent problems facing many governments is waste management. Despite healthy recycling […]


Journal of Commercial Biotechnology seeks Associate Editors

The Journal of Commercial Biotechnology seeks applications for two volunteer Associate Editors. Posts are for renewable 1-2 year terms, with the potential to advance to Managing Editor. Duties include soliciting submissions, working with authors to improve promising manuscripts, managing blinded peer-review, communicating with authors and reviewers, submitting editorials, and assisting the Chief Editor as required. […]


The Role of Cell Line Authentication in Today’s Biotechnology World

This is a guest post from Erin M. Hall. Erin is the Technical Leader at Genetica DNA Laboratories, Inc. located in Cincinnati, OH. Do you have a response to Erin’s post? Respond in the comments section below. It is estimated that 18-36% of all actively growing cell line cultures are misidentified and/or cross-contaminated with another […]


International Bioentrepreneurship Education Conference

The Journal of Commercial Biotechnology is sponsoring the first International Bioentrepreneurship Education Conference. The conference is be an opportunity to connect and begin to discuss best practices in bio-entrepreneurship education. Attendees will share global education programs currently being offered, and will identify any gaps in education today. The program will focus on academic, credit-bearing degrees […]


Introducing the new BiotechBlog Intern

Please welcome Fintan Burke, BiotechBlog’s new intern. Fintan will be contributing regular posts to BiotechBlog. Fintan is a student at the School of Biotechnology at Dublin City University. His main fields of interest include biomedical therapies and recombinant organisms.  Fintan may be contacted at fintan.burke2@mail.dcu.ie .  


Guest Post: Biotechnology Patent Trolls

This is a guest post from the BiotechBlog Intern,  Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin City University. Do you have a response to Fintan’s post? Respond in the comments section below. According to a BDO industry report, a smallUS biotech company in 2010 enjoyed average revenues of around […]


Seeking global biotech/innovation data sets for Scientific American

I’m back at work on the next issue of Scientific American Worldview, and I’m looking for interesting data sets that tell compelling stories about biotechnology and innovation in a comparative country-by-country basis. Some of the datasets we’ve featured are agricultural biotechnology adoption, stock market liquidity, and corruption. Some of the specific themes I’m looking for […]


Drug Patent Expirations in February 2012

Drug Patent Expirations in February 2012 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration VISUDYNE Qlt verteporfin 6,074,666 Feb 5, 2012 GANIRELIX ACETATE INJECTION Organon Usa Inc ganirelix acetate 4,801,577 Feb 5, 2012 ALINIA Romark nitazoxanide 5,387,598 Feb 7, 2012 AZILECT Teva rasagiline mesylate 5,786,390 Feb 7, 2012 […]